Ann Dermatol.  2011 Aug;23(3):382-385. 10.5021/ad.2011.23.3.382.

Neonatal Erythema Multiforme: A Case Report

Affiliations
  • 1Department of Dermatology, Seoul National University College of Medicine, Seoul, Korea. daehun@snu.ac.kr
  • 2Chois Skin Clinic, Seoul, Korea.

Abstract

Erythema multiforme (EM) is an extremely rare condition in infancy. To the best of our knowledge, there have been only three cases of neonatal EM described in the literature, and no such cases have been reported in Korea. A preterm neonate born at 35 weeks and six days of gestation presented with multiple annular erythematous patches with a targetoid shape over his entire body at 36 days of age (corrected age of 7 days). He had no systemic symptoms except for transient mild fever. No triggering factor except for hepatitis B and BCG vaccination was found. Neutropenia was noted upon laboratory analysis. Skin biopsy specimens showed findings suggestive of erythema multiforme. The skin lesions improved rapidly upon administration of intravenous methylprednisolone; however, neutropenia continued for a much longer period. The significance of neutropenia with respect to the development of EM was not clarified. There has been no recurrence of skin lesions over a one-year follow-up period.

Keyword

Erythema multiforme; Neonate; Neutropenia

MeSH Terms

Biopsy
Erythema
Erythema Multiforme
Fever
Follow-Up Studies
Hepatitis B
Humans
Infant, Newborn
Korea
Mycobacterium bovis
Neutropenia
Pregnancy
Recurrence
Skin
Vaccination

Figure

  • Fig. 1 (A) The entire body was covered by well-defined erythematous patches with a targetoid shape. (B) Typical targetoid lesions on left leg.

  • Fig. 2 (A) Histologic section showing a lymphocytic infiltration in the upper dermis with papillary edema (H&E, ×200). (B) Vacuolar change in the basal cell layer (black arrow), and necrotic keratinocytes (white arrow) within the epidermis (H&E, ×400).


Reference

1. Huff JC, Weston WL, Tonnesen MG. Erythema multiforme: a critical review of characteristics, diagnostic criteria, and causes. J Am Acad Dermatol. 1983. 8:763–775.
Article
2. Edmond BJ, Huff JC, Weston WL. Erythema multiforme. Pediatr Clin North Am. 1983. 30:631–640.
Article
3. Weston WL, Morelli JG. Herpes simplex virus-associated erythema multiforme in prepubertal children. Arch Pediatr Adolesc Med. 1997. 151:1014–1016.
Article
4. Brice SL, Huff JC, Weston WL. Erythema multiforme. Curr Probl Dermatol. 1990. 2:5–25.
Article
5. Dikland WJ, Oranje AP, Stolz E, van Joost T. Erythema multiforme in childhood and early infancy. Pediatr Dermatol. 1986. 3:135–139.
Article
6. Johnston GA, Ghura HS, Carter E, Graham-Brown RA. Neonatal erythema multiforme major. Clin Exp Dermatol. 2002. 27:661–664.
Article
7. Torrelo A, Moreno M, Prada I, Celma ML, Zambrano A. Erythema multiforme in a neonate. J Am Acad Dermatol. 2003. 48:5 Suppl. S78–S79.
Article
8. Custer JW, Rau RE, Lee CK. The harriet lane handbook. 2008. 18th ed. Philadelphia: Mosby;360.
9. Ashkenazi S, Metzker A, Rachmel A, Nitzan M. Erythema multiforme as a single manifestation of cow's milk intolerance. Acta Paediatr. 1992. 81:729–730.
Article
10. Nanda S, Pandhi D, Reddy BS. Erythema multiforme in a 9-day-old neonate. Pediatr Dermatol. 2003. 20:454–455.
Article
11. Wine E, Ballin A, Dalal I. Infantile erythema multiforme following hepatitis B vaccine. Acta Paediatr. 2006. 95:890–891.
Article
12. Korting HC, Vieluf D. Erythema multiforme and dermatitis seborrhoides infantum as concomitant id-reactions to widespread candidosis in a suckling. Mycoses. 1991. 34:415–417.
Article
13. Kliegman RM, Behrman RE, Jenson HB, Stanton BF. Nelson textbook of pediatrics. 2007. 18th ed. Philadelphia: WB Saunders;2744.
14. Dostrovsky A, Sagher F. Dermatological complications of BCG vaccination. Br J Dermatol. 1963. 75:181–192.
15. Dogliotti M. Erythema multiforme--an unusual reaction to BCG vaccination. S Afr Med J. 1980. 57:332–334.
16. Tschen EH, Jessen RT, Robertson G, Becker LE. Erythema multiforme as a complication of BCG scarification technique. Arch Dermatol. 1979. 115:614–615.
Article
17. Baley JE, Stork EK, Warkentin PI, Shurin SB. Neonatal neutropenia. Clinical manifestations, cause, and outcome. Am J Dis Child. 1988. 142:1161–1166.
18. Funke A, Berner R, Traichel B, Schmeisser D, Leititis JU, Niemeyer CM. Frequency, natural course, and outcome of neonatal neutropenia. Pediatrics. 2000. 106:45–51.
Article
19. James RM, Kinsey SE. The investigation and management of chronic neutropenia in children. Arch Dis Child. 2006. 91:852–858.
Article
20. Weston WL. Steroids in erythema multiforme (EM). Pediatr Dermatol. 2000. 17:75–83.
Article
21. Prendiville JS. Erythema multiforme and steroids. Pediatr Dermatol. 2000. 17:75–83.
Article
22. Renfro L, Grant-Kels JM, Feder HM Jr, Daman LA. Controversy: are systemic steroids indicated in the treatment of erythema multiforme? Pediatr Dermatol. 1989. 6:43–50.
Article
23. Rasmussen JE. Erythema multiforme in children. Response to treatment with systemic corticosteroids. Br J Dermatol. 1976. 95:181–186.
Full Text Links
  • AD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr